Japan· JP-2190048F1029
アコラミジス塩酸塩
A acoramidis product containing アコラミジス塩酸塩, registered in Japan by アレクシオンファーマ, on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Acoramidis is registered in 14 of 19 countries.
Countries holding a registration under ATC C01EB25 (acoramidis), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 9 of them publish a price we can compare per daily dose
Acoramidis · ATC C01EB25
14 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of acoramidis costs, country by country.
Normalised to the WHO defined daily dose (1.424 g), the median price runs from $0.17 in France to $300.19 in Switzerland — a ×1790 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Acoramidis · price per daily dose (1.424 g)
USD · FX 28 Sept 2026
- CH Switzerland$300.19
- FR France$0.17
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- アコラミジス塩酸塩
- Manufacturer
- アレクシオンファーマ
- Country
- Japan (JP)
- ATC code
- C01EB25
- ATC class
- Acoramidis
- Defined daily dose
- 1.424 g, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under C01EB25
Acoramidis, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d8bdad8a-fd80-4922-82bd-f6053d25f857 GET /v1/drugs/d8bdad8a-fd80-4922-82bd-f6053d25f857?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "４００ｍｇ１錠",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "2190048F1029",
"category": "内用薬",
"price_yen": 8979,
"generic_name": "アコラミジス塩酸塩",
"product_name_jp": null,
"therapeutic_class": "2190",
"transitional_expiry": null
}See everything about acoramidis.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.